988|10000|Public
5000|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> {{to a new}} vaccine/immunisation for the {{prevention}} and/or prophylaxis against measles virus infection and to a pharmaceutical or therapeutic composition {{for the treatment of}} IBD (Inflammatory Bowel Disease); particularly Crohn's Disease and Ulcerative Colitis and regressive behavioural disease (RBD) (also referred to as [...] "Pervasive Developmental Disorder).|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> {{generally}} to cinnamate crosslinkers. Specifically, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to gels, biochips, and functionalized surfaces useful as probes, in assays, in gels, and for drug delivery, {{and methods of}} making the same using a newly-discovered crosslinking configuration...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to the {{utilization}} of ADAMTS 3 metalloprotease. More specifically, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to a method of producing fully processed mature VEGF-C polypeptide by a cell and a method of cleaving VEGF-C polypeptides. Furthermore, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to different uses of ADAMTS 3, ADAMTS 3 inhibitors or compositions comprising ADAMTS 3 or ADAMTS 3 inhibitors, and a method of treating a lymphatic disorder. In addition, the invention relates to a method of producing VEGF-Cbinding molecules...|$|E
40|$|The various {{embodiments}} of <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> {{generally to}} high strength foam {{materials and methods}} of making the same. More particularly, various embodiments of <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> to high strength foam materials comprising pozzolans, such as cenospheres derived from fly ash. An embodiment of <b>the</b> <b>present</b> <b>invention</b> comprises, a pozzolan foam material comprising a pozzolan, an alkali, a silicate, and an organosilicon compound. Various embodiments of <b>the</b> <b>present</b> <b>invention</b> are directed to strong, lightweight materials that are environmentally-friendly and can be economically manufactured. Georgia Tech Research Corporatio...|$|R
40|$|Embodiments {{according}} to <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> generally to PAG bilayer and PAG-doped unilayer structures using sacrificial polymer layers that incorporate a photoacid generator having a concentration gradient therein. Said PAG concentration being higher in a upper portion of such structures {{than in a}} lower portion thereof. Embodiments {{according to}} <b>the</b> <b>present</b> <b>invention</b> also <b>relate</b> to a method of using such bilayers and unilayers to form microelectronic structures having a three-dimensional space, and methods of decomposition of the sacrificial polymer within the aforementioned layers. Georgia Tech Research Corporatio...|$|R
40|$|Novel {{substituted}} [2 -(1 -piperazinyl) ethoxy]methyl compounds. <b>The</b> <b>present</b> <b>invention</b> <b>related</b> to novel substituted [2 -(1 -piperazinyl) -ethoxy]methyl {{compounds of formula}} STR 1 {{in which}} R. sub. 1 represents a [...] CONH. sub. 2, [...] CN, [...] COOH, [...] COOM or [...] COOR. sub. 3 group, M being an alkali metal and R. sub. 3 [...] . 0 info:eu-repo/semantics/publishe...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{a method}} for {{reinforcing}} mineral-based materials using reinforced fiber material. More particularly, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> {{a method for}} more uniformly dispensing a fiber material with a mineral-based material, such as cement paste. Institute Of Paper Science And Technology, Inc...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{a crystal}}. In {{particular}} <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to a crystal of the N-domain of ACE protein. The present invention also relates to methods, processes, domain, specific modulators, pharmaceutical compositions and {{uses of the}} N-domain crystal and the structure co-ordinates thereof...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{methods and}} {{pharmaceutical}} compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to a ligand of the sonic hedgehog signaling pathway {{for use in}} the cardioprotection of a subject who experienced a myocardial infarction...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>related</b> to <b>the</b> {{preservation}} of a liquid biological sample. The biological sample {{is exposed to}} a preservative containing at least about 0. 15 g of sodium benzoate and at least about 0. 025 g of citric acid per 100 ml of sample. The biological sample may be collected in a vessel or an absorbent mass. The biological sample may also be exposed to a substrate and/or a vehicle...|$|R
40|$|The various {{embodiments}} of <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> to compositions, apparatus, {{and methods}} comprising sorbent fibers. More particularly, various embodiments of <b>the</b> <b>present</b> <b>invention</b> are directed towards sorbent fiber compositions for temperature swing adsorption processes. Various embodiments of <b>the</b> <b>present</b> <b>invention</b> comprise sorbent fiber compositions, apparatus comprising {{a plurality of}} sorbent fibers, and methods of using {{the same for the}} capture of at least one component from a medium, for example CO 2 from flue gas. Georgia Tech Research CorporationExxonmobil Research And Engineering Compan...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> is <b>related</b> to an {{isolated}} and purified polypeptide which {{amino acid sequence}} presents more than 70 % with the sequence SEQ ID NO 1. <b>The</b> <b>present</b> <b>invention</b> is also <b>related</b> to the nucleotide sequence encoding said amino acid sequence, the inhibitor directed against said sequences and their use in the diagnosis, treatment and/or prevention of lung injuries or diseases and oxidative stress-related disorders...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to sub-millimeter wave {{frequency}} heterodyne imaging systems. More specifically, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to a sub-millimeter wave frequency {{heterodyne detector}} system for imaging {{the magnitude and}} phase of transmitted power through or reflected power off of mechanically scanned samples at sub-millimeter wave frequencies...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{the fields}} of life {{sciences}} and food, feed or pharmaceutical industry. Specifically, the invention relates to novel peptides, pilus structures, polynucleotides as well as vectors, host cells, products and pharmaceutical compositions comprising the polynucleotides, peptides or pilus structures. The invention also relates to gene clusters and antibodies. Furthermore, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to methods for producing the peptides or pilus structures or producing the products comprising the peptides or pilus structures. Furthermore, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to treatments as well as uses and methods for screening bacterial strains, for reducing or inhibiting the adhesion of pathogenic bacteria, promoting the adhesion of bacterial cells to the mucus and for modifying immune response in a subject. Still, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to methods for detecting probiotic bacterial strains or pathogen strain...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{a method}} for {{detecting}} particles and a particle sensor arrangement. More specifically, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to a method and arrangement for detecting particles in a gas flow, e. g. from a diesel combustion engine. The method comprises the steps of; forcing a [...] . [...] ...|$|E
40|$|The various {{embodiments}} of <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> {{generally to}} sorbent fiber compositions. More particularly, various embodiments of <b>the</b> <b>present</b> <b>invention</b> are directed towards sorbent fibers for pressure swing and temperature swing adsorption processes. Various embodiments of <b>the</b> <b>present</b> <b>invention</b> comprise a sorbent composition, comprising a fiber comprising {{a plurality of}} tortuous pathways; and a sorbent material, wherein the sorbent material is in fluid communication {{with at least a}} portion of the plurality of tortuous pathways. Aspects of <b>the</b> <b>present</b> <b>invention</b> comprise compositions, devices and methods of using sorbent fiber compositions. Georgia Tech Research Corporatio...|$|R
40|$|WO 15049314 A 1 [EN] Embodiments of <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> to a {{level shifter}} circuit (10) {{comprising}} a resistor (12) and a current regulator circuit (18). The resistor (12) is connected between an input (14) and an output (16) of the level shifter circuit (10). The current regulator circuit (18) is designed to influence a current through the resistor (12) such that an output voltage (Uaus) of the level shifter circuit (10) does not exceed a maximum permissible value...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> is <b>related</b> to oligonucleotides for the {{specific}} identification of Staphylococci species which nucleotide sequence has between 15 and 350 base pairs, preferably between 15 and 45 base pairs, obtained from the 'consensus' femA nucleotide sequence (CNS) of the figure or its complementary strand. <b>The</b> <b>present</b> <b>invention</b> is also <b>related</b> to a method and a diagnostic device using said oligonucleotide for the identification of various types of Staphylococci species strains...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{biocidal}} agents {{designed to}} protect industrial products against microbial, bacterial, fungal and algal infections. In particular, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to co-crystals containing 3 -iodopropynyl butylcarbamate (IPBC) and to compositions containing said co-crystals which have improved physical, chemical and workability properties compared {{with the use of}} IPBC...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{a device}} for {{calibrating}} a radiation detector {{system that is}} used for measuring the radionuclide intake of those exposed to radioactive materials. In particular, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to a device that simulates a human chest and lungs with a modicum of internal radiation for use in calibrating radiation detectors...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to a {{new method}} of {{texturing}} a glass surface. In further aspects, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to the resulting textured glass surface; to a photovoltaic device comprising the textured glass surface; and, to use of the textured glass surface for scattering light. Electrical Sustainable EnergyElectrical Engineering, Mathematics and Computer Scienc...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> is a {{nanoparticle}} mixture or suspension or nanofluid comprising nonmagnetically sensitive nanoparticles, magnetically sensitive nanoparticles, and surfactant(s). <b>The</b> <b>present</b> <b>invention</b> also <b>relates</b> to {{methods of}} preparing {{and using the}} same. Georgia Tech Research CorporationSouth Dakota Board Of Regent...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>related</b> {{generally}} to severing materials, and more particularly to severing or weakening materials through explosively induced, augmented shock waves. Explosive cords {{are placed in}} grooves on the upper surface of the material to be severed or weakened. The explosive cords are initiated simultaneously to introduce explosive shock waves into the material. These shock waves progress toward the centerline between the explosive cords and the lower surface of the material. Intersecting and reflected waves produce a rarefaction zone on the centerline to fail the material in tension. A groove may also be cut in the lower surface of the material to aid in severing or weakening the material...|$|R
40|$|The <b>invention</b> <b>relates</b> to the {{determination}} of the level, maintenance and/or performance of germination of a seed lot, by quantification of the protein EM 6, belonging to the group of Late Embryogenesis Abundant (LEA) proteins. <b>The</b> <b>present</b> <b>invention</b> further <b>relates</b> to antibodies permitting the quantification of the protein EM 6...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> {{generally}} to vaccine strains of Brachyspira hyodysenteriae. In particular, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to isolated live vaccine strains of B. hyodysenteriae lacking {{one or more}} virulence factors. The present invention also relates to methods of identifying and preparing vaccine strains, as well as vaccine compositions against diarrhoeal diseases and methods and kits for diagnosing same...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{isolated}} {{nucleic acid}} sequences involved in, or capable of, the biosynthesis of polyacetylenic compounds with anti-fungal activity and especially isolated {{nucleic acid sequences}} derived from Collimonas fungivorans. Further, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to methods for identifying the present isolated nucleic acids, the use thereof for identification of homologous nucleic acids in other organisms or the use thereof for the biosynthesis of polyacetylenic compounds with anti-fungal activity. Further, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to novel polyacetylenic compounds with anti-fungal activity. Specifically, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to isolated nucleic acids encoding one or more proteins involved in the synthesis of a polyacetylenic compound with antifungal activity wherein said isolated nucleic acid comprises a nucleic acid sequence having at least 70 %, preferably at least 80 %, more preferably at least 90 %, most preferably at least 95 % identity with SEQ ID No. 1. ...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{the field}} of au-tomotive applications. In particular, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to a {{differential}} for wheeled vehicles and a wheeled vehicle equipped with such a differential. In more details, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to an electro-mechanical differential module realized by driving both wheels of a common axle by means of a corresponding electric motor. Stili in more detail, the present invention relatesto an electromechanical differential module allow-ing to transfer traction power between the two wheels of the same axle, so as to realize the active contrai of the torque on the wheels of the same axle, for example by increasing the torque on one wheel and decreasing the torque on the other wheel. Furthermore, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to an electromechanical differential module, wherein power may be transferred within the two wheels of a common axle without the involvement of the battery of the vehicl...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> is <b>related</b> to {{a method}} for {{removing}} or reducing the effects of detergents upon germination and/or growth of a micro-organism present in a aqueous culture medium, characterised in that a sufficient amount {{of one or more}} enzyme(s) is added to said aqueous culture medium of said micro-organism...|$|R
40|$|An {{autonomous}} {{computer based}} method and system is described for personalized production of videos such as team sport videos such as basketball videos from multi-sensored data under limited display resolution. Embodiments of <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> to <b>the</b> selection of a view to display from among the multiple video streams captured by the camera network. Technical solutions are provided to provide perceptual comfort {{as well as an}} efficient integration of contextual information, which is implemented, for example, by smoothing generated viewpoint/camera sequences to alleviate flickering visual artefacts and discontinuous story-telling artefacts. A design and implementation of the viewpoint selection process is disclosed that has been verified by experiments, which shows that the method and system of <b>the</b> <b>present</b> <b>invention</b> efficiently distribute <b>the</b> processing load across cameras, and effectively selects viewpoints that cover the team action at hand while avoiding major perceptual artefacts...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> {{generally}} <b>relates</b> to binary {{or higher}} order semiconductor nanoparticles doped with a metallic element, and thermoelectric compositions incorporating such nanoparticles. In one aspect, <b>the</b> <b>present</b> <b>invention</b> provides a thermoelectric composition comprising {{a plurality of}} nanoparticles each of which includes an alloy matrix formed of a Group IV element and Group VI element and a metallic dopant distributed within the matrix...|$|R
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to {{peptides}} binding to the thymidylate synthase protein, {{in particular}} to human thymidylate synthase (hTS) protein, {{for the treatment of}} cancer. <b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to peptides that can bind at a binding site located at the interface of thymdylate synthase protein. These peptides range from 3 to 10, preferably 4 - 8 amino acids and have a sequence that binds to each subunit of the thymidylate synthase dimer at the level of dimer interface, stabilizing the dimeric inactive form of the thymdylate synthase enzyme. In addition, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to pharmaceutical compositions comprising these compounds as active agents, and uses thereof for the treatment of cancer and to reverse or/and be active in cancer drug resistance. <b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to peptides binding to the thymidylate synthase protein, m particular to human thymidylate synthase (hTS) protein, for the treatment of cancer. <b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to peptides that can bind at a binding site located at the interface of thymdylate synthase protein. These peptides range from 3 to 10, preferably 4 - 8 amino acids and have a sequence that binds to each subunit of the thymidylate synthase dimer at the level of dimer interface, stabilizing the dimeric inactive form of the thymdylate synthase enzyme. In addition, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to pharmaceutical compositions comprising these compounds as active agents, and uses thereof for the treatment of cancer and to reverse or/and be active m cancer drug resistance...|$|E
40|$|The present {{invention}} {{related to}} the field of three-dimensional scanning. In particular, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> to a system and a method for the advanced scanning of surfaces and for the simulation of the dynamic deformation of surfaces. Still more in particular, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> t a system and a method particularly appropriate for scanning and simulating the deformation of anatomical surfaces...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> <b>relates</b> to a biphasic {{superabsorbent}} {{and partially}} biodegradable material comprising a biodegradable and/or compostable polymeric phase and a non-biodegradable superabsorbent cross-linked polymer phase. Furthermore, <b>the</b> <b>present</b> <b>invention</b> <b>relates</b> {{to a process}} {{for the production of}} said superabsorbent material and the use thereof to contain and/or absorb and/or separate liquids, in particular aqueous liquids, preferably contaminated ones, and/or biological fluids...|$|E
40|$|<b>The</b> <b>present</b> <b>invention</b> is <b>related</b> to {{a method}} that enables and {{improves}} wide bandgap homoepitaxial layers to be grown on axis single crystal substrates, particularly SiC. The lateral positions of the screw dislocations in epitaxial layers are predetermined instead of random, which allows devices to be reproducibly patterned to avoid performance degrading crystal defects normally created by screw dislocations...|$|R
40|$|The various {{embodiments}} of <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> {{generally to}} femto-relay systems and methods. An exemplary embodiment of <b>the</b> <b>present</b> <b>invention</b> provides a femto-relay system comprising a relay-radio, a femto-radio, a joint femto-relay resource management module, and an IP-backhaul QoS monitoring module. The relay-radio is {{in communication with}} a macro-cell base-station. The femto-radio is in communication with the relay-radio and configured to route signals between a core network {{and at least one}} femto-cell user equipment through an IP-backhaul link. The joint femto-relay resource management module is configured to intelligently manage radio resources between the femto-radio and the relay-radio to reduce cross-tier interference. The IP-backhaul QoS monitoring module is configured to monitor a QoS being delivered by the IP-backhaul link and notify the relay-radio to route signals between the femto-cell user equipment and core network through the macro-cell base-station if the QoS fall below a predetermined threshold. Georgia Tech Research Corporatio...|$|R
40|$|The various {{embodiments}} of <b>the</b> <b>present</b> <b>invention</b> <b>relate</b> {{generally to}} compositions, systems, and methods for altering rates of catalysis. More particularly, the various embodiments of <b>the</b> <b>present</b> <b>invention</b> are directed toward compositions, systems, and methods for enzymatic hydrolysis of polysaccharides, such as cellulose and starch. An aspect of <b>the</b> <b>present</b> <b>invention</b> comprises {{a method for}} altering the rate of conversion of a substrate into a product comprising: providing a substrate in a carrier; mixing a reactant and a co-factor with the carrier to form a substantially homogeneous mixture of the reactant, the co-factor, and the substrate in the carrier; and reacting the reactant with the substrate {{in the presence of}} the co- factor to convert at least a portion of the substrate into the product, wherein the reaction rate of the reactant with the substrate {{in the presence of the}} co-factor is different than the reaction rate of the reactant with the substrate in the absence of the co-factor. Georgia Tech Research Corporatio...|$|R
